Disclosed is a fixation implant for tightly securing ligament transplants and the like in or on bones.
In the event of a fracture of the cruciate ligament, in many cases a ligament transplant is used, whose end is attached in one hole pre-drilled into the femur and one pre-drilled into the tibia. The attachment of the ligament transplant is carried out in many cases by means of so-called interference screws. Interference screws can include, for example, conically tapering bone screws of different external diameters that are provided with external threading. With such interference screws, the ligament transplant, in most cases a tendon, is fixed in a pre-drilled bone bed. The fixing of the ligament transplant is done in this case by clamping between the wall of the hole in the bone and the interference screw. Interference screws can be cannulated, so that when screwing into the bone, torque can be transferred over the entire length of the screw. As a result, excessive screw-in resistance causing the interference screw to break can be prevented. In addition to metal interference screws, interference screws made from biocompatible plastics can be used, which can also be resorbable.
In the fixation of ligament transplants to eliminate cruciate ligament fractures, the transplanted tendon can be injured by excessively strong squeezing. The transplanted tendon can have the property of mechanically relaxing, by which the clamping force of the interference screw or an alternative clamp fastening, for example a plate and screws, can be reduced, and as a result, the tendon can slide out of the bone bed again. Tendons have a slippery consistency. To fix this slippery tendon in the bone bed, interference screws and such fixation elements can be equipped with retaining ribs. In the case of the interference screws, the external threading can perform this function. In the clamping in the bone bed, great force is exerted on the tendon, which can be concentrated on the threaded edges or the edges of the retaining ribs. As a result, it can lead to damage of the tendon. To counteract such damage, interference screws with rounded threaded edges can be used. Such screws can have the drawback that they offer inadequate retention relative to the tendon and can form an inadequate positive fit on the boundary wall of the bone hole.
A tendon is softer than a bone. However, a tendon can offer specific compression relative to an interference screw that is screwed into a bone bed, a greater resistance than the bone itself. This can result in the surgeon exerting excessive screw-in torque when screwing in the interference screw in order to overcome this elevated resistance. As a result, in addition to the tendon, the surrounding bone may also be damaged. The tendon is a viscoelastic tissue, to which the volume can adapt when maintaining pressure over time. This can result in a volume reduction of the transplant to be fixed with the result that the clamping force of the fixation element that is used is reduced, and it can result in a loosening between the fixation element and tendon. Because of the above-described problem, a surgeon may be inclined to screw a considerably larger interference screw into the bone canal than that which corresponds to the diameter with which the bone canal was drilled, with this being done even though one end of the tendon projects into the bone canal. This measure may be used, for example, in older patients whose bone substance no longer offers sufficient hold. Owing to the massive displacement of bone and tendon, the interference screw with the larger diameter can then cause the bone and tendon to be displaced in or from the drilled hole at one point, which no longer corresponds to the anatomically desired insertion point. For example, only in the case of successful healing in such cases can an unnecessarily large hole remain in the bone, which in the case of resorbable screw material often heals only with scar tissue and not with bone substance. The combination of tendon damage, tendon volume reduction, bone expansion and still weaker fixation can result in a loosening between tendon and interference screw or the same fixation elements and in an unreliable transplant fixation. This can ultimately result in a failure of the treatment.
In U.S. Pat. No. 5,084,050, a fixation element in the form of a bone pin is described. Over time, upon contact with bodily fluids, the bone pin that is designed as a hollow body can exhibit certain swelling properties after its implantation, by which its outer diameter increases. The bone pin is used to attach metal bone screws in the bone tissue. Accordingly, a threaded structure is provided in the interior of the bone pin. The outer contour of the bone pin is provided with rounded ribs or a structure that consists of spherical surfaces to protect the surrounding bone substance as much as possible. For a fixing of ligament transplants between the outer wall of the bone pin and the bone substance, the fixation element that is described in U.S. Pat. No. 5,084,050 is hardly suitable, since the latter is only inadequately clamped because of the rounded outer contour of the bone pin. As another possible application of the fixation element, the fixing of ligament-bone cylinders inside the bone pin with subsequent ingrowth of the bone is described in U.S. Pat. No. 5,084,050. Upon swelling of the hollow bone pin that is optionally closed on one side, it is primarily the central receptacle hole for the metal screw or the bone cylinder that is closed. In this case, however, little or no outward pressure is produced.
In U.S. Patent Application Publication No. 2008/0167717, a combination that consists of a bone-fixing plate and bone screws is described. The bone screw can have an area that can swell upon contact with bodily fluids to achieve a tight connection between the bone-fixing plate and the bone screw by enlarging the outer diameter of this area. For example, a clamp fixing of a ligament transplant in a bone bed between the outside of the bone screw and the wall of a hole in the bone is not mentioned in this document.
Various exemplary embodiments of so-called suture anchors are described in U.S. Pat. No. 6,152,949. Suture anchors are cylindrical fixation elements that are anchored in bone or soft tissue to fix muscle tissue with a thread that is attached to the anchor. The thread can be run through an axial hole in the suture anchor. The suture anchors described there can also be produced from a material that swells upon contact with bodily fluids. For example, suture anchors are not suitable for a clamp fixation of ligament transplants in bone beds.
According to an exemplary aspect, disclosed is a fixation implant for tightly securing a ligament transplant on or in a bone, the fixation implant comprising: an elongated body that includes a front end, and at least partially contains an expandable material that, after implantation, exerts an expansion pressure on a surrounding bone substance, wherein the elongated body includes an outer wall which includes, at some areas, profiles that extend substantially transverse to a longitudinal direction, wherein the elongated body on its rear end has engagement means for an insertion instrument, or an opening in a central receptacle for an expansion body, wherein the expandable material is arranged substantially along the entire longitudinal extent of the elongated body, and wherein the expandable material is arranged such that, upon expansion, the expandable material exerts pressure on the areas that includes the profiles in such a way that the external diameter of the body increases.
According to an exemplary aspect, disclosed is a method of tightly securing a ligament transplant in or on a bone, the method comprising: implanting the fixation implant according to an exemplary aspect into a surrounding bone substance.
Other exemplary embodiments of the disclosure follow from the description below with reference to the drawings. Any diagrammatic representations in the drawings are not necessarily true to scale.
a and 2b show two views of a second embodiment that is modified relative to
a and 3b show two views of a third embodiment in the form of an interference screw, in accordance with an exemplary aspect;
a and 4b show two views of a fourth embodiment in the form of an interference screw, in accordance with an exemplary aspect;
a and 9b show another embodiment of a fixation implant that is designed for the fixing of several ligament transplants, in accordance with an exemplary aspect;
a and 10b show another embodiment of a fixation implant, in accordance with an exemplary aspect;
According to an exemplary aspect, provided is a fixation element for fastening ligament transplants and the like to or in bones, which initially fixes the transplant and maintains the clamping pressure on the ligament transplant despite the volume shrinkage of the transplant.
According to an exemplary aspect, a fixation implant for tightly securing ligament transplants and the like on or in bones is provided that has exemplary features.
An exemplary fixation implant can be used, for example, to tightly secure ligament transplants and the like on or in bone tissue. It can have an elongated body that has a front end for application and at least in places includes an expandable material that exerts an expansion pressure on a surrounding bone substance after implantation. The body can have an outer wall, which is equipped at least in places with profiles that run substantially crosswise to the longitudinal extension. On its rear end, the body can be equipped with an engagement means for an insertion instrument, or it can have an opening in a central receptacle for an expansion body. The expandable material can be arranged substantially over the entire longitudinal extension of the body. The areas that are provided with profiles can be exposed to pressure by the expandable material in such a way that the external diameter of the body increases.
For example, by the fixation implant having an expandable material, which can be arranged substantially over the entire longitudinal extent of its body, as uniform a pressure as possible can be exerted on the ligament transplant and on the bone structure surrounding the fixation implant. For example, the pressure develops ab initio, i.e., directly after the insertion of the fixation implant, and remains, even if a widening of the receptacle hole in the bone takes place. The fixation implant can thus have a self-readjusting function.
For example, the expansion pressure and the readjusting function are ensured by the expandable material, which can comprise, for example, an elastically compressible biocompatible plastic. In an exemplary embodiment, the expandable material comprises a material that can swell upon contact with bodily fluids. By the fixation implant already exerting pressure on the ligament transplant and the surrounding bone structure immediately after the introduction into the receptacle hole in the bone and because of its self-readjusting function, the external diameter of the fixation implant can be kept comparatively small. As a result, only a relatively small receptacle hole has to be made in the bone, which can have an advantageous effect on the healing process. For example, the external diameter of the fixation implant can be approximately 5 mm to 10 mm. By an open geometry of the fixation implant that is as thin as possible, the amount of the material that is used can be reduced. At the same time, the ingrowth of the ligament transplant may be desired, since bone and scar tissue can grow through the gaps.
By the expansion pressure that develops ab initio, as large a contact surface as possible, which promotes a large-surface ingrowth, can be achieved between the bone and the ligament transplant. The fixation implant can also be arranged at the free end of the ligament transplant (e.g., of a tendon) in its interior. Then, the thus charged transplant can be pressed into the receptacle hole in the bone. By the expansion pressure and the self-adjusting effect of the fixation implant, the ligament transplant can be pressed on all sides onto the bone wall, by which a large contact surface that promotes ingrowth can be achieved.
In an exemplary embodiment, the readjustment of the fixation implant in which the material that is used swells is achieved. For example, resorbable or non-resorbable polymers can be used. For example, an addition of calcium phosphates to high-molecular polylactides (e.g., 200,000 gmol) can result in a constant volume increase for 40 weeks. The calcium phosphate can lead to an osmotic difference that results in absorption of water. The thus produced pressure in the fixation implant can result in its swelling. For example, when using 10 mol % tricalcium phosphate, the volume in an in vitro test at 37° C. increases by 3% after 2 weeks, by 13% after 10 weeks, and by almost 25% after 24 weeks. In vivo studies show that when adding only 1% sodium phosphate, for example, a volume increase of 13% can be achieved after 2 weeks, 30% after 6 weeks, and around 100% after 28 weeks. Accelerated in-vitro studies at an elevated temperature of 55° C. show, for example, that the addition of 10 mol % sodium phosphate as early as after 10 days results in a volume increase of 100%, while the same polylactide without additives undergoes a volume increase of only 4% in the same period.
A counterpressure, e.g., bone tissue, can result in a smaller degree of swelling. Thus, the fixation implant can already have a self-readjusting effect starting at an early point in time and swelling. The expandable material can comprise a resorbable polymer with a molecular weight of <100,000 g/mol. For example, when the value drops below this molecular weight limit, the strength of the polymer can decrease significantly more quickly. This can be substantiated with an increased mobility of the molecule. For example, polylactides with an L/D ratio of approximately 70/30 can increase significantly in volume starting from about 20 weeks. In the case of polylactides from racemic D, L-lactide, for example, the volume increase can be carried out as early as after 10 weeks. This can correspond approximately to the point in time when the value drops below a molecular weight of approximately 100,000 g/mol.
In another exemplary embodiment, the fixation implant can include several layers of expandable materials, which, on the one hand, make possible the initial fixation, and, on the other hand, make possible a subsequent upholding of the pressure by self-adjustment. This can be carried out by, for example, the introduction of pores into the fixation implant, via which the liquid absorption and thus swelling behavior can be controlled.
The biocompatible expandable material can also be produced from non-resorbable materials. For example, it can be a non-resorbing hydrogel or a salt-filled cushion, which takes up liquid and swells by osmotic effects. Combinations of expandable materials and non-expandable materials are also possible. Thus, in an additional exemplary embodiment, the outside part of the fixation implant can include comparatively hard shells with a slip-proof outer contour, while the core area of the fixation implant is produced from an expandable, relatively soft material. Textile materials can also be used.
In an exemplary embodiment, the expandable material of the fixation implant mechanically is not heavily pressure-loaded, for example, in connection with silicone or other soft components. Exemplary embodiments therefore provide for the expandable material to be arranged in the fixation implant in such a way that it can optimally exert its pressure. For example, this can be a zone, extending over the length of the fixation implant, in its interior. To control a swelling behavior and the swelling speed, a swellable material that is used can be arranged in such a way that, for example, bodily fluid cannot force its way outward, but can penetrate into the interior. In an exemplary embodiment, an outer shell that encloses the swellable material is produced from a porous material, for example, calcium phosphate, PEEK, polylactide, polyglycolide or the like. Porosity can also be achieved by smaller bores, holes or capillaries. For example, bodily fluid can get into the interior to form swellable material, while the latter itself, however, remains collected within the shell. In another exemplary embodiment, the swellable material is surrounded by a mechanically resistant, liquid-permeable biocompatible membrane.
For example, to mitigate or prevent too much of the expandable material from going outward over time, the expandable material can be designed with varying expansion behavior or for setting a gradient with respect to the expansion. For example, when using pairs of salt in silicone or salt in polyurethane deep within the swellable material, a larger proportion of salt (e.g., 40-80 percent by volume) can be provided, while the proportion of salt on the surface of the expandable material can be relatively small (e.g., 0-10 percent by volume). As a result, the interior of the swellable material can expand considerably more, and an overall more homogeneous distribution of force can be achieved. At the same time, the expandable material can thus be held on site.
In an exemplary embodiment, the fixation implant is designed according to a type of an interference screw with an external diameter of approximately 5 mm to 10 mm. Unlike a comparative interference screw, such exemplary interference screw can, for example, have a solid body and is not cannulated. On its rear end, a cover plate that includes a rigid, non-expandable material can be molded-on, in which an engagement means with torque transfer surfaces can be formed. For example, the engagement means cab be a Torxx or cross-slot receptacle, whose depth is less than ¼ of the axial length of the fixation implant. For example, the fixation implant, which can have the form of an interference screw, can include or entirely consist of, for example, poly-D,L-lactide with an L-lactide to D-lactide ratio of 85/15. This material can have a molecular weight of <100,000 g/mol and can have a proportion of approximately 10% (w/w) sodium phosphate. For example, immediately after the introduction into the receptacle hole in the bone, the implant begins to take up bodily fluid, and the swelling process begins. The counterpressure of the fixation transplant and the surrounding bone can counteract an increase in volume. For example, if the fixation implant buckles, the counterpressure decreases, and the fixation implant further swells. Over the course of 1-2 years, the fixation implant can decay completely. By then, for example, the ingrowth process of the ligament transplant that is first held by clamping will be long since completed.
For example, an alternative variant of the fixation implant includes two outer-ribbed half-shells that are pressed outward by an inside wedge. A ligament transplant can be fixed by clamping between the fixation implant and the bone wall. The half-shells can include or consist of pure poly-D,L-lactide with a ratio of 70% L-lactide and 30% D-lactide with a molecular weight of approximately 200,000 g/mol. The wedge can include or consists of polylactide-co-glycolide with a molecular weight of <100,000 g/mol, which is mixed with >50% (w/w) tricalcium phosphate (TCP). The high content of TCP can allow a quick diffusion of bodily fluid in the wedge and thus a quick swelling of the same. This can lead to a pushing apart of the half-shells and thus to a self-readjusting effect of the fixation implant. The wedge can degrade within approximately 6-9 months, and the half-shells within approximately 2 years.
In an exemplary embodiment,
In an exemplary embodiment, an exemplary fixation implant shown in
In an exemplary embodiment,
In an exemplary embodiment, an exemplary fixation implant that is depicted in
In an exemplary embodiment, an exemplary fixation implant 1 that is depicted in
In an exemplary embodiment,
In an exemplary embodiment, an exemplary fixation implant that is diagrammatically depicted in
In an exemplary embodiment, an exemplary fixation implant 1 that is depicted in
In an exemplary embodiment, an exemplary fixation implant that is depicted in
For example, for insertion, the expandable material can be compressed, and the shell segments 32a-32d can be pressed apart after the introduction. As a result, the tendon material S can be pressed against the wall of the bone canal B. If the bone canal B is further widened, the material 9 that can swell upon contact with bodily fluids cab ensure that the clamping pressure is maintained on the tendons S. The outer surface of the shell segments adjacent to the tendon material can have an elevated roughness or be equipped with ribs, mandrels or edges to keep the tendon material from sliding. The sections facing the bone canal B, shell segments 32a-32d, can have additional anchoring aids such as edges, spikes or mandrels, so that they find a better hold in the bone canal B.
In an exemplary embodiment, an exemplary fixation implant depicted in
In exemplary embodiments,
In an exemplary embodiment,
In an exemplary embodiment, the exemplary fixation implant 51 depicted in
In an exemplary embodiment,
In an exemplary embodiment,
In an exemplary embodiment, an exemplary fixation implant that is depicted in
In an exemplary embodiment, an exemplary fixation implant depicted in cross-section in
In an exemplary embodiment,
In an exemplary embodiment,
The exemplary embodiments shown in
For example, the materials that can be used for the fixation implant can be biocompatible and can be resorbable or else non-resorbable. Non-resorbable polymers can include biocompatible polymers, such as, e.g., polyethylene, polypropylene, polyethylene terephthalate, polyether ketone, polyether ether ketone, polyvinyl chloride, polycarbonate, polyamides, polyimides, polystyrene, polyacrylamide, polybutadiene, polytetrafluoroethylene, polyurethane, polysiloxane-elastomers, polyether ether ketone, polysulfone, polyether imides, polyacetates, poly-paraphenylene, terephthalamide, silicones, and carbon- or glass-fiber-reinforced composite materials. In an exemplary embodiment, hydrogels can also be of natural or synthetic origin, which swell by the absorption of water but do not dissolve, such as, e.g., poly-2-hydroxyethyl-methacrylate (PHEMA).
Resorbable or partially resorbable polymers which can be used can be polyhydroxy ester, polyorthoester, polyanhydride, polydioxanone, polyphosphazene, polyhydroxyalkanoate, polypropylene fumerate, polyester amide, polyethylene fumerate, polylactide, polyglycolide, poly-ε-caprolactone (PCL), polytrimethylene carbonate, polyphosphazene, polyphosphates, polyvinyl alcohol, polymaleic acid (b) or polymaleic acid ester, poly-p-dioxanone and copolymers, modifications or mixtures of the same. As examples, lactate/glycolide copolymers, lactate/tetramethylene glycolide copolymers, lactate-trimethylene carbonate copolymers, lactate/alpha-valerolactone copolymers, lactate/ε-caprolactone copolymers, polydepsipeptides (glycine-DL-lactate copolymer or lactate/ethylene oxide copolymers), or, from the group of polyhydroxyalkanoates, e.g., PHB [polyhydroxybutyrate)], or PHB/PHV (polyhydroxybutyrate/-valerate), can be mentioned.
Also suitable are, for example, mixtures or copolymers with vinyl polymers, e.g., based on poly-β-maleic acid, aliphatic polyamides, aliphatic polyurethanes, e.g., polyurethanes that consist of polyethylene glycol (PEG) diols or polycaprolactone diols and diisocyanates, polypeptides, e.g., synthetic polyamino acids and poly-α-amino acids, e.g., poly-β-lysine or polybenzyl glutamate, polyurethane-diol glycosaminoglycan, polysaccharides, e.g., dextran derivatives, chitin or chitosan derivatives or hyaluronic acid esters, alginates, gelatins or cellulose derivatives, modified proteins, e.g., partially cross-linked collagen or fibrin, or modified carbohydrate polymers.
For example, to match the elasticity or the swelling behavior, polymers can be mixed with softeners, e.g., from monomers or oligomers of the same polymers, from biocompatible softeners, such as, e.g., acetyl tributyl citrate, citric acid, etc.
For example, so-called super-absorbers, which are able to take up a multiple of their own weight, for example, up to 1000 times, of liquids, for example, water or distilled water, can also be used. Chemically, in the current state of the art, the super-absorber is a copolymer that consists of acrylic acid (propenoic acid, C3H4O2) and sodium acrylate (sodium salt of acrylic acid, NaC3H3O2).
For example, to increase the swellability of materials or only to make the swellability possible, hydrophilic substances, for example, in the form of particles or nanoparticles, can be added to the polymers. These particles produce an osmotic effect. Exemplary substances can include salts, such as, e.g., sodium chloride, but also calcium phosphates, such as, e.g., monocalcium phosphate monohydrate, monocalcium phosphate anhydrate, dicalcium phosphate dihydrate, dicalcium phosphate anhydrate, tetracalcium phosphate, calcium orthophosphate, calcium pyrophosphate, α-tricalcium phosphate, 13-tricalcium phosphate, apatites, such as, e.g., hydroxyl apatite, calcium sulfates, sodium sulfates, sodium phosphates, etc.
An exemplary feature of exemplary embodiments is that they can increase their external diameter immediately after their insertion into a receptacle hole in the bone, i.e., ab initio, and thus exert pressure on the surrounding bone substance. The selection of the materials can be carried out in this case in such a way that an expansion pressure of 5 MPa is not exceeded. For example, the fixation implant is designed in such a way that it has a low elastic compressibility. As a result, on the one hand, the insertion of the fixation implant into the bone hole can be facilitated, and, on the other hand, an anchoring in the bone hole and a clamp fixing of a ligament transplant ab initio can be ensured independently of swelling or an increase in diameter owing to liquid absorption and retention.
It will be appreciated by those skilled in the art that the present invention can be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The presently disclosed embodiments are therefore considered in all respects to be illustrative and not restricted. The scope of the invention is indicated by the appended claims rather than the foregoing description and all changes that come within the meaning and range and equivalence thereof are intended to be embraced therein.
Number | Date | Country | Kind |
---|---|---|---|
529/10 | Apr 2010 | CH | national |
This application claims priority as a continuation application under 35 U.S.C. §120 to PCT/CH2011/000075, which was filed as an International Application on Apr. 11, 2011 designating the U.S., and which claims priority to Swiss Application No. 00529/10 filed in Switzerland on Apr. 13, 2010. The entire contents of these applications are hereby incorporated by reference in their entireties.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/CH2011/000075 | Apr 2011 | US |
Child | 13652095 | US |